Solomon BJ, Bauer TM, Ignatius Ou SH, Liu G, et al. Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study. J Clin Oncol 2022 May 23:JCO2102278. doi: 10.1200/JCO.21.02278.
PMID: 35605188